- Featured News /
AI offers the greatest potential to transform health systems from being reactive to proactive, predictive, and even preventive.
- Featured News /
COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.
- Featured News /
Standing by people with sickle cell disease and their families
- Featured News /
Latest oncology resources and news surrounding Novartis data featured at American Society of Clinical Oncology (ASCO)
- Featured News /
As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
- Statement /
Novartis condemns the war in Ukraine and has been providing humanitarian support, financial donations as well as considerable volumes of medicines to those people impacted by the war.
- Featured News /
Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach.
- Featured News /
European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.
- Featured News /
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.
- Featured News /
Driven by our passion for patients and grounded in our industry-leading pipeline of 45+ different compounds across 70+ development programs, Novartis is rapidly advancing novel cancer treatment approaches in areas of great medical need.
Pagination
- ‹ Previous page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- …
- 20
- › Next page